Manik Madaan/med.psu.edu
Jul 6, 2026, 20:31
Manik Madaan: Master Transfusion Reactions for USMLE In Less Than 60 Seconds
Manik Madaan, Resident Doctor at Penn State University, shared a post on LinkedIn:
”Master Transfusion Reactions for USMLE In Less Than 60 Seconds
Acute Hemolytic Reaction (ABO mismatch)
- Mechanism: type II hypersensitivity, recipient anti-A / anti-B antibodies attack donor red blood cells – intravascular hemolysis
- Presentation: minutes to 24 hours; fever, chills, flank pain, hypotension, hemoglobinuria; can trigger DIC (disseminated intravascular coagulation)
- Tx: STOP transfusion now, IV fluids; next step – Coombs (positive)
Febrile Non-Hemolytic Reaction (most common)
- Mechanism: cytokines from donor white blood cells build up in storage (no hemolysis)
- Presentation: 1 to 6 hours; fever plus chills; Coombs negative
- Tx: stop to rule out hemolysis, then acetaminophen; prevent with leukoreduction
Allergic / Anaphylactic Reaction
- Mechanism: type I hypersensitivity to donor plasma proteins; severe equals IgA (immunoglobulin A)-deficient patient with anti-IgA antibodies
- Presentation: within minutes; mild equals hives plus itching (no fever); severe equals anaphylaxis
- Tx: antihistamines; anaphylaxis equals epinephrine; washed / IgA-free products if IgA deficient
TRALI (transfusion-related acute lung injury)
- Mechanism: donor anti-leukocyte antibodies activate lung neutrophils – non-cardiogenic pulmonary edema
- Presentation: within 6 hours; dyspnea, hypoxia, bilateral infiltrates, fever plus LOW blood pressure, normal BNP (heart-strain marker)
- Tx: stop, oxygen; top cause of transfusion death
TACO (transfusion-associated circulatory overload)
- Mechanism: too much volume too fast – cardiogenic pulmonary edema
- Presentation: after 6 hours (or heart disease); AFEBRILE plus HIGH blood pressure, high BNP, neck-vein distension
- Tx: slow or stop transfusion, sit upright, diuretics
Want more USMLE Cheatsheets?”

Stay updated with Hemostasis Today.
-
Oct 11, 2026, 16:57Shiny K. Kajal: Japan Advances Artificial Blood via Haemoglobin Vesicles Trials
-
Oct 11, 2026, 16:45Luca Scarcia: Rescue Stenting Superior When Posterior Circulation Thrombectomy Fails
-
Oct 11, 2026, 16:27Giuseppe Bellelli: Reevaluating Anticoagulation Net Benefit in Frail Older Adults
-
Oct 11, 2026, 16:17Johnathan Whetstine: How Does MYC Go From 2 Copies to an Amplified Oncogene?
-
Oct 11, 2026, 16:03Parth Parmar: Practical Guidelines for Managing Venous Thromboembolism
-
Oct 11, 2026, 15:31Muhammad Alvi: CASPR Study Explores Treatment Response Across ESUS Phenotypes
-
Oct 11, 2026, 15:15Thalassaemia International Federation Joins ASCAT 2026 to Advance Sickle Cell and Thalassaemia Care
-
Oct 11, 2026, 15:14Challenges and Perspectives on Gene Therapy in Hemophilia A – Seminars in Thrombosis and Hemostasis
-
Oct 11, 2026, 15:07Neysa Rahardjo: Platelet Estimation Pitfalls and Discrepancy Resolution